During the last three months, 8 analysts shared their evaluations of Albemarle (NYSE:ALB), revealing diverse outlooks from bullish to bearish.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $70.12, a high estimate of $87.00, and a low estimate of $57.00. This upward trend is evident, with the current average reflecting a 4.66% increase from the previous average price target of $67.00.

Analyzing Analyst Ratings: A Detailed Breakdown

A clear picture of Albemarle's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

For valuable insights into Albemarle's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Albemarle analyst ratings.

All You Need to Know About Albemarle

Understanding the Numbers: Albemarle's Finances

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Negative Revenue Trend: Examining Albemarle's financials over 3M reveals challenges. As of 30 June, 2025, the company experienced a decline of approximately -7.02% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.41%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Albemarle's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.24% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Albemarle's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.11% ROA, the company effectively utilizes its assets for optimal returns.

Debt Management: Albemarle's debt-to-equity ratio is below the industry average. With a ratio of 0.46, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

How Are Analyst Ratings Determined?

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.

Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.